A study on therapeutic and anti-inflammatory effects of probiotic in asthmatic patients referred to kowsar semnan hospital

A study on therapeutic and anti-inflammatory effects of Saccharomyces cerevisiae boulardii probiotic in asthmatic patients referred to kowsar semnan hospital

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20151228025732N54

Enrollment

Registered

2020-05-27

Start date

2020-04-21

Completion date

Unknown

Last updated

2020-06-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Asthmatic. Mild intermittent asthma with status asthmaticus

Interventions

Intervention 1: Intervention group: In addition to routine asthma treatments

250 mg of probiotic capsules under the brand name daily yeast for 3 month, 1 to 2 times a day. Before and after the intervention, 7 cc of blood is taken to check for factors such as CRP, peripheral bl

Eligibility

Sex/Gender

All

Age

No minimum to 60 Years

Inclusion criteria

Inclusion criteria: Informed consent Up to 60 years of age Asthma confirmed by a pulmonologist

Exclusion criteria

Exclusion criteria: Kidney failure Acute or chronic infection Cancer

Design outcomes

Primary

Measure	Time frame
Interleukin-5 (IL-5). Timepoint: Before and after intervention. Method of measurement: ELISA.;Eosinophils. Timepoint: Before and after intervention. Method of measurement: Cell count by examining peripheral blood smears.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactBahador Bagheri

Semnan University of Medical Sciences

are20935@gmail.com+98 23 3345 1336

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026